Mirae Asset Global Investments’s AC Immune ACIU Stock Holding History

Mirae Asset Global Investments’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8K	Sell	4,552 -695	-13%	-$1.92K	﹤0.01%	1566
2026 Q1	$14.4K	Buy	5,247 +368	+8%	+$1.14K	﹤0.01%	1464
2025 Q4	$15.3K	Buy	4,879 +997	+26%	+$3.15K	﹤0.01%	1567
2025 Q3	$11.2K	Buy	3,882 +3	+0.1%	+$7	﹤0.01%	1565
2025 Q2	$7.88K	Buy	3,879 +570	+17%	+$992	﹤0.01%	1518
2025 Q1	$6.55K	Buy	3,309 +13	+0.4%	+$33	﹤0.01%	1502
2024 Q4	$9K	Sell	3,296 -281	-8%	-$878	﹤0.01%	1524
2024 Q3	$13.4K	Buy	3,577 +624	+21%	+$2.18K	﹤0.01%	1480
2024 Q2	$11.7K	Buy	+2,953	New	+$9.77K	﹤0.01%	1446
2021 Q3	–	Sell	-1,181	Closed	-$9K	–	1733
2021 Q2	$9K	Buy	+1,181	New	+$8.16K	﹤0.01%	1687

Other funds holding ACIU

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mirae Asset Global Investments's ACIU Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its AC Immune (ACIU) stake by 13% in Q2 2026, selling an estimated $1.92K and leaving 4,552 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1566.

Mirae Asset Global Investments first reported a position in ACIU in Q2 2021 and has held it in 10 quarters since. The position peaked at $15.3K in Q4 2025. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

Mirae Asset Global Investments held 4,552 shares of AC Immune worth $10.8K as of Q2 2026.
Mirae Asset Global Investments sold 695 AC Immune shares in Q2 2026, an estimated $1.92K.
AC Immune made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1566 holding.
Mirae Asset Global Investments first reported a position in AC Immune in Q2 2021 and has held it in 10 quarters since.
Mirae Asset Global Investments's AC Immune position peaked at $15.3K in Q4 2025.
43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.